Form 8-K - Current report:
SEC Accession No. 0001477932-24-005537
Filing Date
2024-09-05
Accepted
2024-09-05 13:00:32
Documents
16
Period of Report
2024-09-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bglc_8k.htm   iXBRL 8-K 27085
2 AMENDED AND RESTATED BYLAWS bglc_ex31.htm EX-3.1 34565
  Complete submission text file 0001477932-24-005537.txt   200759

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bglc-20240904.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20240904_lab.xml EX-101.LAB 15742
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20240904_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20240904_pre.xml EX-101.PRE 9996
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20240904_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT bglc_8k_htm.xml XML 4168
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

IRS No.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41750 | Film No.: 241280767
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)